M. Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am
6
cells/rat) transplantation, the number of TdT-mediated dUTP nick end-labeling-positive cells was significantly lower in the MSCHO-1 group than in the MSC group (12.1 Ϯ 1.0 cells/field vs. 26.5 Ϯ 2.6, P Ͻ 0.05) on the 4th day after cell transplantation. On the 28th day, increased capillary density associated with decreased infarction size was observed in the MSCHO-1 group (1,415 Ϯ 47/mm 2 with 21.6 Ϯ 2.3%) compared with those in the MSCs group (1,215 Ϯ 43/mm 2 with 28.2 Ϯ 2.3%, P Ͻ 0.05), although infarction size relative to area at risk was not different in each group at 24 h after transplantation. These results demonstrate that MSCHO-1 exhibit markedly enhanced antiapoptotic and anti-oxidative capabilities compared with MSCs, thus contributing to improved repair of ischemic myocardial injury through cell survival and VEGF production associated with the PI 3-kinase/ Akt pathway. apoptosis; cell transplantation; heme oxygenase-1; mesenchymal stem cells; myocardial ischemia THE TRANSPLANTATION OF BONE marrow cells, embryonic stem cells, and cardiac stem cells has been reported to contribute to myocardial regeneration or neovascularization after ischemic myocardial injury (6, 23, 29, 45) . Of these cells, mesenchymal stem cells (MSCs) may differentiate not only into osteoblasts, chondrocytes, neurons, and skeletal muscle cells but also into vascular endothelial cells (2, 35) . Indeed, bone marrow-derived MSCs are pluripotent and can ameliorate ischemic myocardial injury (30, 31) . MSCs might also have paracrine effects for cell protection or proliferation through cytokine secretion (32) . However, some transplanted cells cannot survive in ischemic hearts, suggesting that their efficacy is limited in the clinical setting (48) .
Recently, heme oxygenase-1 (HO-1), an anti-oxidant and anti-inflammatory protein (36) , was shown to play an important role in organ transplantation (46) . HO-1 catalyzes the enzymatic degradation of heme to carbon monoxide, biliverdin, and iron, with all three products showing biological activity (37) . HO-1 is sensitive to upregulation by a variety of stress mediators such as ischemia, hypoxia, oxidative stress, and inflammatory cytokines (37) . Therefore, HO-1 may represent an endogenous defensive system (7, 38) with the ability to attenuate ischemic myocardial injury (43) . However, few data exist regarding the impact of transiently HO-1-overexpressed MSCs (MSC HO-1 ) on ischemic myocardial injury.
In the present study, we transiently overexpressed the human HO-1 gene in MSCs using the lipofection method. We examined whether MSC HO-1 had anti-apoptotic and/or anti-oxidative stress capabilities in vitro and in vivo, determined the levels of cytokine such as vascular endothelial growth factor (VEGF) by these cells under oxidative stress, and examined whether the transplantation of MSC HO-1 improved cardiac function in a myocardial infarction model.
MATERIALS AND METHODS
Preparation of bone marrow-derived MSCs. All of the experiments were performed in accordance with the Guidelines of the Animal Care Committee of Kanazawa University, which approved our experimen-tal protocol. MSC expansion and isolation were performed according to previously described methods (31) . Briefly, bone marrow cells were isolated from male Lewis rats (200 -300 g; Japan SLC, Hamamatsu, Japan) by flushing the femoral and tibial cavities with PBS, and culturing the resultant cells in standard medium [GIBCO's minimum essential medium-␣ (MEM-␣) with 10% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin]. Nonadherent cells were removed, and the medium was replaced. The adherent, spindle-shaped MSCs were propagated through four to five passages (Ͼ5 ϫ 10 6 cell/rat). Cell culture experiments were performed at 37°C and in 5% humidified CO2.
Phenotypic analysis and multilineage differentiation assay. Standard flow cytometry (JSAN Biosciences, La Jolla, CA) techniques were used to determine the cell surface epitope profile of MSCs, including CD14, CD29, CD34, CD43, CD73, CD90, SSEA1, and SSEA4. Cells were incubated for 30 min at 4°C with APC-conjugated mouse monoclonal antibodies against rat CD14 (BD Biosciences Pharmingen, San Diego, CA), CD90 and C29 (Fitzgerald, Acton, MA), CD34 (Santa Cruz Biotechnology, Santa Cruz, CA), and SSEA4 (R&D Systems, Minneapolis, MN), or with fluorescein isothicyanate (FITC)-conjugated mouse monoclonal antibodies against rat CD45 (Santa Cruz), CD73 (BD Biosciences Pharmingen), and SSEA1 (Abcam, Cambridge, MA).
We characterized the cultured cells, based on their differentiation into either adipoid or osteoid cells. MSCs were cultured with the Adipogenesis Assay Kit (0.5 mM 3-isobutyl-1-methylxanthine, 10 g/ml insulin, 1 M dexamethasone; Chemicon International, Temecula, CA). On the 10th day, cultures were stained with oil red O, and the dye content was quantified by isopropanol elution and spectrophotometry. MSCs were grown in osteogenic growth medium (glycerol 2-phosphate, 50 g/ml ascorbic acid phosphate, 10 nM dexamethasone, and collagen type I) using the Mesenchymal Stem Cell Osteogenesis Kit (Chemicon International). On the 17th day, the cultures were stained with Alizarin Red Solution.
Transient gene transfection. To assess the efficiency of commonly used transfection protocols in vitro, cultured MSCs (5 ϫ 10 6 Ϯ 0.1 ϫ 10 6 cells) were transfected with green fluorescent protein (GFP) using the lipofection method (Lipofectamine 2000; Invitrogen, Carlsbad, CA). Lipofectamine reagent used at a DNA-to-Lipofectamine 2000 ratio of 1:2 achieved maximal efficiency for adherent cells. The expression of GFP was assessed by fluorescence microscopy and quantitative real-time RT-PCR. Transfection of cultured MSCs by a human HO-1 plasmid DNA was performed under these effective conditions. The plasmids used were the human HO-1 construct, pRc/cytomegalovirus (CMV)-sHHO-1, containing the entire proteincoding region, the Xhol/Xbal fragment (Ϫ63/924) of pHHOl, in a correct orientation under the promoter/enhancer of CMV (40) .
RNA extraction and quantitative real-time RT-PCR. To assess the expression of HO-1, levels of HO-1 expression were determined on days 1, 2, 4, and 7 posttransfection using a real-time quantitative RT-PCR. Briefly, total RNA was extracted from cells with guanidine isothiocyanate (RNeasy Mini Kits; QIAGEN, Valencia, CA). Total RNA (500 ng) was used to synthesize first-strand cDNA by SuperScript using the First-Strand Synthesis System for RT-PCR (Invitrogen). The cDNA product was amplified by PCR. Expression of mRNA was quantified with SYBR Green two-step for human HO-1 and glyceraldehydes-3-phosphate dehydrogenase (GAPDH). The PCR reaction mixture was prepared using the SYBER Green PCR Master Mix (PE Applied Biosystems, Foster City, CA). Each sample was analyzed in duplicate using the conditions recommended by the manufacturer. The following primers were used: human HO-1 sense primer, 5=-CAACATCCAGCTCTTTGAGG-3=, and anti-sense primer, 5=-GGCATAAAGCCCTACAGCAA-3=; and GAPDH sense primer, 5=-TGGTATCGTGGAAGGACTCATGAC-3=, and anti-sense primer, 5=-ATGCCAGTGAGCTTCCCGTTCAGC-3=. After initial denaturation at 95°C for 60 s, a two-cycle procedure was used (denaturation at 95°C for 15 s, annealing and extension at 60°C for 1 min) for 40 cycles in an ABI PRISM 7700 Sequence Detector System (PE Applied Biosystems). Using manufacturer's software, real-time PCR data were plotted as the ⌬Rn fluorescence signal vs. the cycle number. The cycle threshold was defined as the cycle number at which the ⌬Rn crosses this threshold. The expression of each gene was normalized to GAPDH mRNA content and calculated relative to the control using comparative cycle threshold methods.
Assessment of cell apoptosis during serum deprivation and hypoxia. For the experiments, cultured MSCs were used after the fourth passage. MSCs or MSC HO-1 were washed with serum-free MEM (Invitrogen), placed in serum-free MEM, and then incubated in an anaerobic bench. MSCs or MSC HO-1 apoptosis, similar to what may be occurring in ischemic myocardial injury, was induced under cell culture conditions by serum deprivation and hypoxia over different periods of time (0 -24 h) (49) .
Cell damage was assessed using the fluorescent dye annexin V-FITC apoptosis Detection Kit I (BD Biosciences Pharmingen). Flow cytometric analysis of annexin V-FITC and propidine iodide (PI)-stained cells (ϳ1 ϫ 10 5 cells) was performed for each sample. Cells were washed with cold PBS and then resuspended in 100 l of Oxidative stress and analysis of cell viability. For oxidative experiments, MSCs or MSC HO-1 were seeded in 96-well microculture plates (2 ϫ 10 4 cells/well, passage 4) for 24 h after which the culture medium was replaced with fresh medium containing different H2O2 concentrations (100 M to 1.5 mM) for 2 h (44). After this incubation period, the medium was replaced with fresh medium, and cell viability and functional capacity were assessed using the MTS assay (CellTier 96 Aqueous One Solution Cell Proliferation Assay; Promega, Madison, WI), containing 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS). MTS solution (20 l) was added to each well, and the microculture plates were incubated for another 1-4 h at 37°C in a humidified, 5% CO2 atmosphere. The quantity of formazan product was measured by absorbance at 490 nm with a microtiter plate reader (Multiskan JX Version 1.1; Thermo Fisher Scientific, Waltham, MA).
Assessment of cytokine production and effect of phosphatidylinositol 3-kinase/protein kinase B pathway inhibitors. We investigated whether VEGF production in the culture medium from MSCs or MSCHO-1 after 24 h in the culture medium (10 cm culture dish) was altered after an additional 2 h with or without the addition of H2O2. VEGF levels were measured using enzyme-linked immunosorbent assay kits (Rat VEGF Immunoassay; R&D Systems).
Under the same oxidative condition, we pretreated MSCs or MSCHO-1 with specific phosphatidylinositol 3-kinase (PI 3-kinase)/ protein kinase B (Akt) pathway inhibitors such as LY-294002 (Promega) and wortmannin (Calbiochem, Gibbstown, NJ). MSCs or MSCHO-1 were exposed to LY-294002 (50 M) or wortmannin (100 nM) for 1 h before H 2O2 loading, and the VEGF concentrations were determined.
Animal model of myocardial ischemia. A total of 80 male Lewis rats (250 -300 g) were used in these experiments. These isogenic rats served as donors and recipients of MSCs to simulate autologous implantation. Experiments were performed in accordance with the Guidelines of the Animal Care Committee of Kanazawa University. Myocardial infarction was created by ligation of the left anterior descending artery (LAD) as described previously (31) . Briefly, rats were anesthetized with pentobarbital sodium (30 mg/kg body wt ip) and ventilated with a volume-regulated respirator with supplemental oxygen. The heart was exposed through a left thoractomy, and the proximal LAD was ligated with a 6 -0 Prolene suture. At 60 min after coronary ligation, 72 rats had survived (survival rate 90%).
The surviving rats were randomly divided into the following three groups: control group (n ϭ 24), MSC transplantation group (n ϭ 24), and MSC HO-1 transplantation group (n ϭ 24). A single injection of MSCs (5 ϫ 10 6 Ϯ 0.1 ϫ 10 6 cells in 250 l of PBS/rat) or MSCHO-1 (5 ϫ 10 6 Ϯ 0.1 ϫ 10 6 cells in 250 l of PBS/rat) was performed in the infarcted border zone at five sites (50 l/site). The infracted border zone was determined by visual observation of wall motion abnormalities and color change. The LV was divided into the apical, middle, and basal levels, and injections were made in the midposition of five sites (1 apical, 2 middle, and 2 basal level sites). The depth of each injection was controlled by bending a 27-gauge needle 30 degrees at 2 mm proximal to its tip. The control group underwent LAD ligation and PBS injection. Of 72 surviving rats, 18 rats were used for determination of infarct area and risk area at 24 h, 24 rats were used for evaluation of cardiomyocyte apoptosis on the 4th day, and 30 rats were used for evaluation of capillary density and infarct size on the 28th day after transplantation. As for postoperative pain management, animals were treated with buprenorphine (0.03 mg/kg sc) immediately after surgery and then as needed.
Evaluation of MSCs and MSC HO-1 transplantation in myocardial ischemia models. Area at risk was estimated by Evans Blue retrograde perfusion (29) . As for evaluation of HO-1 expression and cell apoptosis, immunofluourescent staining was performed using monoclonal rabbit anti-human HO-1 antibody (Stressgen Biotechnologies, Victoria, BC, Canada), and cardiomyocyte apoptosis was evaluated by TdT-mediated dUTP nick end-labeling (TUNEL) assay using a Fluorescein Apoptosis Detection kit (Apotag; Chemicon International). More than 10 fields/heart in each group were examined in normal, peri-infarct, and infracted areas microscopically. The number of TUNEL-positive cells was counted per high-power field.
Echocardiography. The animal groups were examined on the 28th day after MSC or HO-1 MSC transplantation. After measurement of body weight, rats were anesthetized with pentobarbital sodium and placed in the left lateral decubitus position. Two-dimensional and M-mode recordings (Sonos 5500; PHILIPS, Bothell, WA) were obtained from the short-axis view at the level of the papillary muscles. Heart rate was also monitored by electrocardiography. Anterior wall thickness, posterior wall thickness, left ventricular (LV) diastolic dimension (LVDd), LV systolic dimension (LVDs), and LV ejection fraction (LVEF) were measured in triplicate by an investigator blinded to the treatment condition and recorded as an average of three beats. Percent fractional shortening (%FS) was also calculated as (LVDd Ϫ LVDs)/LVDd ϫ 100. After completion of these measurements, the left and right ventricles were excised and weighed.
Assessment of capillary density and infarct size. Immunofluourescent staining was performed using polyclonal anti-von Willebrand factor (vWF) antibody (Sigma Chemical). For examination of vWF, the specimens were fixed in 10% formaldehyde, embedded in paraffin, and cut into 5-m sections. Capillary vessels within the peri-infarct area were identified by light microscopy after immunostaining with vWF. Transverse sections were randomly obtained from 3 levels (basal, middle, and apical), and 10 randomly selected fields (ϫ200)/ section (n ϭ 10/animal) were analyzed. The number of capillaries in each field was averaged and expressed as the number of capillary vessels. Two examiners who were blinded to treatment assignment performed these morphometric studies. Subsequently, partial 5-m transverse slices from each section were prepared for either hematoxylin and eosin or Masson's trichrome staining.
A microscope equipped with a charge-coupled device camera was used to acquire images of the LV area of each slide. The area at risk, infracted tissue, and total LV areas of each image were measured using an image-analysis system (NIH Image J program). The circumferences of the entire flat LV and the visualized area at risk and infarcted area, as judged from the epicardial and endocardial sides, Fig. 4 . Effect of HO-1 overexpression on cell viability during oxidative stress. Cells were exposed for 2 h to various concentrations of H2O2 (horizontal axis), and cell viability (vertical axis) was evaluated. Data are means Ϯ SE; n ϭ 6. *P Ͻ 0.05 vs. MSCs. were outlined on a clear sheet. We selected representative samples for comparisons at the papillary muscle level in all cases because typical pathological changes were observed at that level. Finally, the infarct size was expressed as a percentage of the total LV area using two slices from the nearby papillary muscle level.
Statistical analysis. Results were statistically analyzed by StatView version 5.0 (SAS, Cary, NC). All data are presented as means Ϯ SE and were analyzed by one-way ANOVA for repeated measures. For further analysis, we used the unpaired Students' t-test or post hoc Bonferroni/Dunn test. Differences were considered significant at P Ͻ 0.05.
RESULTS

Surface phenotype of MSCs and cell differentiation.
The adhered cultured cells from the fourth passage strongly expressed CD29, CD73, CD90, and SSEA-1. In contrast, these cells were negative for CD14, CD34, CD45, and SSEA-4 ( Fig. 1) . As for the differentiation potential of the cultured cells, significant MSC-related adipogeneic and osteogenic capacities were detected, indicating that the cultured cells had properties of MSCs.
Expression of HO-1 and its effect on MSC survival in vitro.
When the DNA-to-lipofectamine 2000 ratio was 1:2, the efficiency of GFP gene transduction was maximum at 78 Ϯ 2%. Therefore, we used the same conditions for HO-1 gene transfection. The levels of HO-1 mRNA were highest at 48 h after transfection (5.8 Ϯ 0.3) compared with those in control (1.0 ϫ 10 Ϫ4 Ϯ 0.1 ϫ 10 Ϫ4 , P Ͻ 0.01), and was decreased on and after 96 h (Fig. 2) . Most MSC HO-1 appeared to adhere continuously to the tissue culture dish, and no morphological changes were evident.
When MSCs or MSC HO-1 were exposed to culture conditions of serum deprivation and hypoxia over different periods of time, the population of annexin V ϩ /PI ϩ MSCs (30 Ϯ 2%) was much greater than that of annexin V ϩ /PI ϩ MSC HO-1 (17 Ϯ 1%, P Ͻ 0.05) after 6 h (Fig. 3, A and B) . As for oxidative stress, the exposure of cells to various concentrations of H 2 O 2 Under these conditions, MSC HO-1 produced 2.1-fold more VEGF than MSCs (Fig. 5B) . Pretreatment with the PI 3-kinase/ Akt pathway inhibitors LY-294002 (50 M) and wortmannin (100 nM), both of which did not affect VEGF production without oxidative stress, significantly decreased VEGF production in MSCs with oxidative stress. Interestingly, LY-294002 and wortmannin also decreased VEGF production in MSC HO-1 with oxidative stress by 78.3 Ϯ 2.9 and 70.2 Ϯ 1.1%, respectively (P Ͻ 0.001; Fig. 5, A and B) .
Expression of HO-1 and its anti-apoptotic effect in a model of myocardial ischemia. HO-1-positive cells were clearly identified around the peri-infarct area in the MSC HO-1 transplanted group (Fig. 6A) , although there were a few HO-1-positive cells in the MSC group. Under these conditions, TUNEL-positive cells were less frequently observed in the MSC HO-1 group (12.1 Ϯ 1.0 cells/field) compared with the control (49.2 Ϯ 4.4) and MSC (26.5 Ϯ 2.6, P Ͻ 0.05; Fig. 6, B and C) groups.
Echocardiography and histology of myocardial ischemia. There were no differences in heart rate between the MSC and MSC HO-1 groups. Compared with the control group, the thickness of the anterior wall was greater and the LV systolic and diastolic dimensions were reduced in the MSC group. Control %FS and LVEF in the present study were not necessarily in line with other control data in rats (16, 31) . Difference in heart rate might contribute to difference in these echocardiographic parameters. Indeed, higher heart rate was associated with lower %FS and LVEF in other studies compared with those in the present study, even in an almost identical experimental procedure. Under these conditions, %FS and LVEF were greater in the MSC group than those in the control group. Interestingly, these parameters were further improved in the MSC HO-1 group compared with the MSC group (Table 1) .
At 24 h after transplantation, the area at risk was 49.2 Ϯ 2.1% in controls and was equivalent in both MSC (50.3 Ϯ 1.4%) and MSC HO-1 groups (48.4 Ϯ 1.5%). Under these conditions, the infarction size relative to the area at risk was 63.3 Ϯ 3.2% in control and was equivalent in both MSC (63.1 Ϯ 1.5%) and MSC HO-1 (62.2 Ϯ 2.2%) groups.
Enhanced angiogenesis with reduced infarct area was prominent in the MSC HO-1 group on the 28th day after cell transplantation. Capillary density was significantly greater in the MSCs group (1,215 Ϯ 43 /mm 2 ) than in the control group (626 Ϯ 15 /mm 2 , P Ͻ 0.05). Capillary density was further increased in the MSC HO-1 group (1,415 Ϯ 47 /mm 2 , P Ͻ 0.05; Fig. 7, A and B) , although there was no significant difference in capillary density in the noninfarcted area with or without MSC transplantation.
Under these conditions, MSC transplantation significantly decreased the size of the myocardial infarct related to the LV (28.2 Ϯ 2.3%) compared with that of controls (38.4 Ϯ 4.7%, P Ͻ 0.05). The infarct size was further reduced in the MSC HO-1 group compared with that in the MSC group (21.6 Ϯ 2.3%, P Ͻ 0.05; Fig. 8, A and B) .
DISCUSSION
Previous experimental studies demonstrated that the transplantation of stem/progenitor cells such as MSCs, bone marrow stem cells, and cardiac stem cells reduced ischemiainduced myocardial tissue injury and improved LV function (6, 23, 29, 45) . However, some clinical studies have shown only modest functional improvement using stem cell therapies (1, 13, 42) . This observation may be explained, in part, by a limited reparative capability of the transplanted cells due to poor viability caused by a lack of resistance to stress-induced cell apoptosis with or without oxidative stress (29) . Indeed, Dai et al. (10) demonstrated that effects of MSC transplantation on preserving cardiac function with acute ischemia were transient for only 4 wk.
HO-1 has been identified as a graft-protective gene in organ transplantations (4, 25, 39) . In an animal model, survival rates of grafted MSCs were improved by transfecting the MSCs with a hypoxia-regulated HO-1 vector (43), consistent with results observed in the present study. However, the mechanism of improved cell survival associated with enhanced tissue repair after HO-1 overexpression remained unclear.
The present study was designed to transplant MSCs that transiently overexpress HO-1 during the early phase of tissue injury, since continuous HO-1 overexpression inhibits regeneration factors such as nitric oxide (9) . Under these conditions, we demonstrated that MSC HO-1 had better anti-oxidative and anti-apoptotic properties than unmodified MSCs. As shown in the in vitro study using H 2 O 2 , overexpressed HO-1 may have an anti-oxidative effect to support MSC survival even after transplantation. As for anti-apoptotic effects, we previously reported that MSC-derived cytokines accelerated the phosphorylation of Akt, which plays a pivotal role in cell apoptosis (34) and activates HO-1 expression and function in the presence of mediators (17) . In addition, MSCs genetically modified with the Akt gene had improved cell viability, metabolic characteristics, and even proliferative capacity (29) . These results suggest a fundamental codependence between HO-1 and Akt in mediating cytoprotection against cell apoptosis or death (8) . Indeed, under oxidative stress, VEGF production from MSC HO-1 was dramatically reduced by the PI 3-kinase/Akt pathway inhibitors. In contrast, the overexpression of Akt can induce a local production of VEGF (41) that also has a direct effect on the survival of cardiomyocytes by activating the downstream Akt cascade system (28) . Thus HO-1 and PI 3-kinase/Akt activities may be related to the anti-apoptotic capabilities of MSCs and cardiomyocytes partially through VEGF production.
Transiently overexpressed HO-1 increased MSC survival. In addition, MSC HO-1 appeared to exert a paracrine action that resulted in further therapeutic benefits such as angiogenesis, because the production of VEGF by MSC HO-1 was 2.1-fold greater than that by MSCs. Actually, capillary density was increased markedly in the MSC HO-1 group. Indirect evidence that HO-1 mediates VEGF-stimulated angiogenesis in vivo suggests that the induction of HO-1 may play an important role in VEGF functions (14, 22) . Previous studies demonstrated that the phenotypic plasticity of MSCs, which allows them to transform into endothelial-like cells, provides an additional rationale for their role in angiogenesis (31, 32) .
It is interesting to consider whether transplanted MSC HO-1 activate c-kit ϩ -positive cardiac progenitor cells, which are self-renewing, clonogenic, and multipotent (3). The present data showed that transplantation of MSC HO-1 rather than MSCs resulted in a reduction of apoptosis of cardiomyocytes in vivo. Additionally, our previous data suggested that MSC HO-1 may support the growth of c-kit ϩ cardiac progenitor cells by enhancing their mobility (34) . Thus both the cell protection and activation and the paracrine effects of MSC HO-1 may contribute to the reduction of tissue injury and preservation of LV function after acute myocardial ischemia.
Our preliminary study demonstrated that the improvement in LVEF was ϳ5% after transplantation of MSCs in clinical patients with dilated cardiomyopathy (33) . Other clinical trials have also shown limited increases in LVEF of between 5 and 9% following bone marrow cell transplantation (1, 13, 20, 42) . The lack of cell viability may be a determinant of the disappointing clinical outcome in such studies. From this viewpoint, we suggest that transplantation of MSC HO-1 may be an alternative therapeutic strategy for myocardial tissue repair, because this strategy improved LVEF in our ischemic model.
In the present study, MSCs were injected in a nonreperfused heart, which was actually different from the current clinical situation in which reperfusion is obtained by percutaneous interventions or thrombolysis. Therefore, having beneficial effects in an infarcted heart without reperfusion observed in the present study does not automatically involve similar effects in a reperfused heart. However, the overexpression of HO-1 was also shown to improve cardiac function in an ischemic-reperfused animal model (47) . Thus MSC HO-1 also may have favorable effects in the reduction of myocardial injury in reperfused as well as nonreperfused states.
Some lipid-lowering drugs such as 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors were shown to significantly increase endogenous HO-1 activity (19, 27) . Indeed, early treatment with these agents could reduce major adverse cardiac events in acute coronary syndrome (5, 12) . Other agents such as erythropoietin, which can activate HO-1 (24) , may also contribute to reducing the infarct size when combined with MSC treatment.
In comparison with other methods such as adenovirus infection, the gene-transfer method with low-dose lipofectamine used in the present study may be safer than that with virus vectors (26) , although lipofectamine has cytotoxic activity at high dosages (18) . Genetic technology using a nonviral carrier such as a cationized polysaccharide may also overcome the shortcomings of gene-transfected MSC therapy (21) .
There remain several limitations. First, the area at risk was not determined in our chronic ligation models because vascular structure could have changed on the 28th day after transplantation, modifying the area at risk at this status. However, the area at risk of our acute occlusion models, in which the same part of the LAD was ligated as in chronic occlusion models, was equivalent in all groups as reported by Mangi et al. (29) . In addition, infarct size of controls in our chronic ligation model (38.4%) was consistent with that reported by Dai et al. (37.8%) (11) . Thus the evaluation of the infarction area in our models could be reliable for comparison.
Second, the application of the present procedure to the acute stages of myocardial ischemia in clinical settings is difficult because the present protocol requires a culture period for cell expansion. Unmodified MSCs that were injected in ischemic myocardium 1 wk after occlusion did not affect the infarction size, although LV function was preserved (10) . Using the Celution stem and regenerative cell-processing system (15), adipose-derived MSCs can be obtained without cell culture, although a large amount of original tissue is necessary to obtain an adequate cell number.
In conclusion, through the enhanced anti-apoptotic and antioxidative capabilities of MSC HO-1 , their use in transplantation has promise in improving myocardial repair after ischemic injury. We suggest that this strategy may be a novel cell-based therapy for ischemic or nonischemic myocardial injury.
